Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs

Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs

Abstract Background Administrative healthcare claims data provide a mechanism for assessing and monitoring multiple sclerosis (MS) disease status across large, clinically representative “real-world” populations. The estimation of MS disease status using administrative claims can be a challenge, howe...

Full description

Bibliographic Details
Main Authors: Michael Munsell, Molly Frean, Joseph Menzin, Amy L. Phillips
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Disease status measure
Retrospective database
Validation
Costs
Online Access:http://link.springer.com/article/10.1186/s12883-017-0887-1

Internet

http://link.springer.com/article/10.1186/s12883-017-0887-1

Similar Items